OverStitch NXT Endoscopic Suture System
← catalyst calendarNCT07276815 · readout in 804 d
Sponsored by Boston Scientific Corporation (industry) · BSX — their whole pipeline →.
Phase
Not applicable
Status
Not yet recruiting
Study type
Interventional
Design
Randomized · Single · Treatment
Enrollment
136estimated
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2026-08-31 | estimated | When the study began enrolling |
| Primary completion | 2028-10-31 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2029-10-31 | estimated | The whole study's end, after follow-up |
| First posted | 2025-12-11 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-07-29 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Weight Loss
Intervention
- Device: OverStitch NXT Endoscopic Suture System
Primary outcomes
what the primary-completion date above is the date OF%TBWL (Defined as the percentage of total body weight loss)
measured At 12 months after the intervention.
The response rate at the 12th month after the intervention
measured At 12 months after the intervention
Permalink · BSX's whole pipeline · Catalyst calendar · Every registered study · What changed